<p>ScN2a cells were treated with compounds from the R and R' (panel A); G (panel B); D, J and Y (panel C); and C series (panel D) at 1, 5, or 10 µM. Control bar (medium) represents intensity density of the blot from wells without compound addition, corresponding to 100% of PrP<sup>Res</sup> content. Quantification of the assay was done by integration of the density of each dot using ImageJ software considering as control the final DMSO concentration in each well. All bars had <b>*</b><i>P</i><0.05 in relation to control except those labeled as NS (non-significant).</p
<p>Box plot analysis of high control and low control data toward Y79 and RB355 cells in absence (-RE...
<p>(A) Automated determination of NIH3T3 cell number in 96-well format. Two-fold serial dilutions of...
<p>A. SK-N-SH cells were treated with 200 µM of PrP106–126, scrambled peptide PrP106–126 (SCR) or DM...
<p>ScN2a cells were treated with the compounds belonging to the L (panels A and B), G, R', R and Y (...
<p>Lysates of ScN2a cells grown in the presence of the compounds for 4-blotted as described in the M...
<p>ScN2a cells were grown for 4-well plates in the presence of compounds from the R series at 1, 5, ...
<p>(A) ScN2a-3-22L cells grown on 12-well plates were cultured in the presence or absence of mAb 44B...
<p>(<b>A.</b>) Percent activity scatterplot for all bioactive compounds screened at single point (12...
<p>PrP<sup>res</sup> after cell screening with test compounds and subsequent cell lysis for western ...
<p><b>A.</b> Correlation of corresponding wells from duplicate plates in the library. Wells with few...
<p><sup>a</sup>Test samples were dissolved in DMSO and then added to cell culture. Final concentrati...
<p><b>A) Compound chemical structures.</b> Compounds are arranged in order of decreasing potency. <b...
<p><b>(A)</b> DEAB dose response curves of 1,000 MIA PaCa-2 cells/well incubated with the indicated ...
<p><b>A</b>) N2a cells and <b>B</b>) ScN2a cells were inoculated for 1.5 hours with increasing dilut...
<p>(A) rPrP PMCA reactions seeded with rPrP-res and serially propagated in the presence of 30 µg/ml ...
<p>Box plot analysis of high control and low control data toward Y79 and RB355 cells in absence (-RE...
<p>(A) Automated determination of NIH3T3 cell number in 96-well format. Two-fold serial dilutions of...
<p>A. SK-N-SH cells were treated with 200 µM of PrP106–126, scrambled peptide PrP106–126 (SCR) or DM...
<p>ScN2a cells were treated with the compounds belonging to the L (panels A and B), G, R', R and Y (...
<p>Lysates of ScN2a cells grown in the presence of the compounds for 4-blotted as described in the M...
<p>ScN2a cells were grown for 4-well plates in the presence of compounds from the R series at 1, 5, ...
<p>(A) ScN2a-3-22L cells grown on 12-well plates were cultured in the presence or absence of mAb 44B...
<p>(<b>A.</b>) Percent activity scatterplot for all bioactive compounds screened at single point (12...
<p>PrP<sup>res</sup> after cell screening with test compounds and subsequent cell lysis for western ...
<p><b>A.</b> Correlation of corresponding wells from duplicate plates in the library. Wells with few...
<p><sup>a</sup>Test samples were dissolved in DMSO and then added to cell culture. Final concentrati...
<p><b>A) Compound chemical structures.</b> Compounds are arranged in order of decreasing potency. <b...
<p><b>(A)</b> DEAB dose response curves of 1,000 MIA PaCa-2 cells/well incubated with the indicated ...
<p><b>A</b>) N2a cells and <b>B</b>) ScN2a cells were inoculated for 1.5 hours with increasing dilut...
<p>(A) rPrP PMCA reactions seeded with rPrP-res and serially propagated in the presence of 30 µg/ml ...
<p>Box plot analysis of high control and low control data toward Y79 and RB355 cells in absence (-RE...
<p>(A) Automated determination of NIH3T3 cell number in 96-well format. Two-fold serial dilutions of...
<p>A. SK-N-SH cells were treated with 200 µM of PrP106–126, scrambled peptide PrP106–126 (SCR) or DM...